Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
-31.5%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $59.01M | +236.6% |
| 2024 | $-43.19M | -406.7% |
| 2023 | $14.08M | -92.3% |
| 2022 | $183.36M | +216.1% |
| 2021 | $-157.92M | +2.1% |
| 2020 | $-161.38M | +0.3% |
| 2019 | $-161.87M | -56.8% |
| 2018 | $-103.23M | -59.1% |
| 2017 | $-64.87M | -170.6% |
| 2016 | $-23.97M | - |